Author

K. K. Sahlberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:chromatin & epigenetic regulation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

A.-L. Borresen-Dale· 2 shared A. Hurtado-Rodriguez· 1 shared A. Mathelier· 1 shared A.-M. Fosdahl· 1 shared E. Fiorito· 1 shared H. Bergholtz· 1 shared J. A. Castro-Mondragon· 1 shared J. Ankill· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A.-L. Borresen-Dale

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Crosstalk between microRNA expression and DNA methylation drive the hormone-dependent phenotype of breast cancer

M. R. Aure, T. Fleischer, S. Bjorklund, J. Ankill, J. A. Castro-Mondragon, Oslo Breast Cancer Research Consortium (OSBREAC), A.-L. Borresen-Dale, K. K. Sahlberg, A. Mathelier, X. Tekpli, V. N. Kristensen

The paper investigates how microRNA expression and DNA methylation interact to drive hormone-dependent breast cancer phenotypes by analyzing two breast cancer cohorts.

Genome Medicine · Apr 29, 2021Peer-reviewedCancer Biology

Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1

S. Gilfillan, S. Wang, M. R. Katika, J. H. Norum, H. Bergholtz, E. Fiorito, S. Nordhagen, Y. Sharma, S. Singh, V. S. Somisety, A.-M. Fosdahl, S. Nord, O. Engebraaten, O. C. Lingjaerde, A.-L. Borresen-Dale, , A. Hurtado-Rodriguez

This study shows that HER2/HER3 signaling and FOXA1 deacetylation drive ER-independent growth in hormone-resistant breast tumors by altering FOXA1 chromatin binding and function.

bioRxiv · Sep 22, 2020 · PreprintCancer Biology